healthcare · FORTIS
Fortis Healthcare
Fortis Healthcare: PE above historical average. NARROW LEADERSHIP regime.
Price
₹948.85
Price 2026-07-30
5 day
+0.02%
Short-term move
1 month
-0.85%
Medium-term
Regime
NARROW LEADERSHIP
62% confidence
Market cap
₹73.4k Cr
neutral sector flow
Market Intelligence Analyst
Understand today's market in about 2 minutes.
“How does today's NARROW LEADERSHIP regime affect Fortis Healthcare (FORTIS) in the healthcare sector?”
Price chart
₹945
+19.14% over period
About Fortis Healthcare
Fortis Healthcare Limited operates as a healthcare delivery service provider in India. The company services in the areas of cardiac science, nephrology, diabetology/endocrinology, foetal medicine, infectious diseases, mental health and behavioral science, oncology, orthopedics, physiotherapy and rehabilitation, rheumatology, urology, nuclear medicine, critical care, emergency and trauma, general surgery, internal medicine, neurointerventional radiology, obstetrics and gynaecology, pediatrics, pediatrics, vascular surgery, and support facilities. It also provides services in the areas of infertility medicine, dental science, endocrine surgery, geriatric medicine, liver transplant and hepatobiliary sciences, neurology, ophthalmology, pain and palliative medicine, pulmonology, thoracic surgery, gastroenterology sciences, dermatology, ENT, haematology, medical generics, neurology, organ transplant, radiology, and transfusion medicines. In addition, the company offers various spectrum integrated healthcare services ranging from clinics to quaternary care facilities and a range of ancillary services, as well as secondary, and tertiary care services. The company's healthcare verticals ...
At a Glance
RSI pattern warning
RSI oversold bounces for this stock succeeded only 0% of the time (avg -7.9% over 14 days) — not a reliable pattern.
52-week position
Trading at 85.9% of 52-week high
Technicals
RSI 14
41.3
Trend
mixed
50 DMA
Below
200 DMA
Above
Key metrics
P/E ratio
70.3
57th pct · 7 quarterly points (limited history)
P/B
7.4
ROE
11.0%
Moderate profitability — 11.0% ROE
Market cap
₹73.4k Cr
Revenue growth
1780.0% YoY
Promoter
35.2%
52-week range
₹757.15 – ₹1,104.3
85.9% of high
RSI (14)
41.3
mixed
vs 50 DMA
Below
DMA ₹960.99
Coverage
100/100
HIGH
Quick Take
Fortis Healthcare: PE above historical average. NARROW LEADERSHIP regime.
Peer comparison
| Stock | Price | 5D | P/E | ROE | Rev growth | Mcap |
|---|---|---|---|---|---|---|
| APOLLOHOSP Apollo Hospitals | ₹8,988 | +1.4% | 65.4 | 21.5% | 1810% | ₹1.3L Cr |
| MAXHEALTH Max Healthcare | ₹1,124.8 | +3.7% | 76 | 14.3% | 1220% | ₹1.1L Cr |
| ASTERDM Aster DM Healthcare | ₹814 | +3.8% | 104.9 | 10.1% | 1820% | ₹40.8k Cr |
| NH Narayana Hrudayalaya | ₹2,080.3 | +4.9% | 50.2 | 19.8% | 7580% | ₹40.7k Cr |
| LALPATHLAB Dr. Lal Pathlabs | ₹1,878.8 | +11.7% | 55.7 | 21.5% | 1660% | ₹28.1k Cr |
| FORTIS Fortis Healthcare | ₹948.85 | +0.7% | 70.3 | 11% | 1780% | ₹73.4k Cr |
Tensions to watch
Promoter holding at 35.2% — neither distress selling nor aggressive buying
No strong insider signal. Watch for changes in promoter stake as a leading indicator.
Key Watchpoints
Breaks above ₹996 (+5%)
Trend reversal confirmation
Breaks below ₹901 (-5%)
Further downside risk
PE reverts to median of 68.7 (7 quarterly points (limited history))
Valuation normalization
Healthcare sector entering leadership
Sector rotation signal